Method for purifying cordycepin, purified cordycepin and application of cordycepin

Through the multi-step treatment of alcohol precipitation and multiple column chromatography techniques, the purification process of Cordyceps sinensis is optimized, the problems of low extraction efficiency and large losses of active ingredients in the existing technology are solved, and high-purity Cordyceps sinensis extraction is achieved. Suitable for large-scale applications.

CN118930597APending Publication Date: 2024-11-12INNER MONGOLIA KUNMING CIGARETTE CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410991002.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing Cordyceps purification methods have problems such as low extraction efficiency, large loss of active ingredients, and long process cycles, especially in terms of retaining active ingredients and discarding invalid ingredients.

Method used

The alcohol precipitate was concentrated by anhydrous ethanol and then flowed through macroporous resin column chromatography, combined with alumina silica gel column and microsphere resin column for multi-step elution and desorption, and optimized by ethanol concentration and flow rate, and finally coagulation by dextran The gel or C18 chromatography column was further purified to achieve high purity Cordycepsin extraction.

Benefits of technology

It significantly improves the purity of Cordyceps sinensis, improves the purity of the initial purified products, optimizes the process steps, reduces the process, and improves the extraction efficiency, which is suitable for large-scale fermentation application research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930597A_ABST
    Figure CN118930597A_ABST
Patent Text Reader

Abstract

The invention discloses a purification method of cordycepin, and relates to the technical field of deep processing of cordyceps militaris. The cordycepin purification method comprises the following steps: (1) carrying out alcohol precipitation on a cordycepin crude extract; (2) performing chromatography on the alcohol precipitation liquid through a first chromatographic column, eluting the first chromatographic column, and collecting a first eluent; (3) removing pigment from the first eluent through an alumina silica gel column; (4) enabling the residual liquid to flow through a microsphere resin column, and adding an ethanol solution for desorption to obtain a second eluent; (5) enabling the second eluent to flow through a second chromatographic column, carrying out gradient elution by adopting an ethanol solution, collecting a third eluent in which the cordycepin peak area accounts for 90% or above, and drying to obtain a purified product; and repeatedly washing and crystallizing the purified product by using absolute ethyl alcohol to obtain purified cordycepin. The purity of the cordycepin obtained by the method is obviously improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to a cordycepin purification method, the purified cordycepin and its application, and relates to the technical field of deep processing of Cordyceps militaris. Background Art

[0002] Cordyceps militaris is a traditional edible fungus in my country with multiple active functions. It has now been artificially cultivated. Many researchers have found differences in the cultivation methods obtained through optimization, indicating that strains from different sources may have different requirements for culture conditions. Therefore, it is necessary to explore and optimize the culture conditions before conducting subsequent experiments. There are many active ingredients in Cordyceps militaris, and cordycepin is one of the representative ingredients, especially in terms of anti-tumor effects. It is particularly important to explore economical, simple and suitable methods for cordycepin fermentation, extraction and purification.

[0003] At present, most of the research on the separation and purification methods of cordycepin at home and abroad focuses on resin adsorption, supercritical extraction, activated carbon binding, liquid chromatography, silica gel column chromatography, etc. Among them, the activated carbon binding method is the earliest separation and purification method. The activated carbon material is simple and easy to obtain, low-priced, and can be injected in large quantities during separation, but the extraction efficiency is relatively low; the more efficient separation and purification methods currently include macroporous adsorption resin method, high-performance liquid chromatography, ion exchange resin method and silica gel column chromatography, but the above methods still have the disadvantages of insufficient extraction, large loss of effective ingredients, multiple processes and long cycles in retaining effective ingredients and discarding ineffective ingredients. Summary of the invention

[0004] The purpose of the present invention is to provide a cordycepin purification method to improve the purity of cordycepin and lay a foundation for its large-scale fermentation application research.

[0005] In order to achieve the above objectives, this application is implemented through the following technical solutions:

[0006] A cordycepic acid and an extraction method thereof, comprising the following steps:

[0007] (S1) taking a crude cordycepin extract, adding anhydrous ethanol until the ethanol concentration in the solution reaches 60%-80%, standing for 12-18 hours, centrifuging and collecting the supernatant to obtain a first supernatant, and concentrating the first supernatant to 3-3.5 times the mass of the first supernatant in a water bath at 50° C.-70° C. to obtain an alcohol precipitate;

[0008] (S2) passing the alcohol precipitate through a first chromatographic column for chromatography, wherein the alcohol precipitate is passed through a first chromatographic column for chromatography, the sample volume is 0.5-2.5 BV, and the sample flow rate is 1-3 BV / h; eluting the macroporous resin to obtain a first eluent, wherein the eluent is 3-5 BV of a 50%-70% ethanol solution;

[0009] (S3) passing the first eluent through an alumina silica gel column at a speed of 2-4 BV / h,

[0010] Collect the remaining liquid;

[0011] (S4) after the residual liquid passes through the microsphere resin column, adding 10%-70% ethanol solution for desorption to obtain a second eluent;

[0012] (S5) passing the second eluent through a second chromatographic column, eluting the second chromatographic column, collecting the eluent with a cordycepin peak area accounting for more than 90%, collecting the third eluent with a cordycepin peak area accounting for more than 90%, and drying to obtain a purified product; repeatedly washing and crystallizing the purified product with anhydrous ethanol to obtain purified cordycepin.

[0013] Specifically, before step (S1), the process further includes extracting a crude cordycepin extract, comprising the following steps:

[0014] (1) drying the fruiting bodies cultivated by the Cordyceps militaris strain at 50-60° C. to constant weight, and crushing the fruiting bodies through a 75-85 mesh sieve to obtain dry matter of the fruiting bodies cultivated by the Cordyceps militaris strain;

[0015] (2) extracting the dry matter of the fruiting bodies cultivated by the Cordyceps militaris strain by water bath reflux, collecting the second supernatant by centrifugation, and concentrating the second supernatant to 3-3.5 times of the second supernatant by mass in a water bath at 50-70° C. to obtain a crude extract.

[0016] Specifically, in step (1), the water bath reflux extraction temperature is 50-90°C, the extraction time is 1-5h, the purification concentration is 10-60%, the solid-liquid ratio is 1:(10-80), and the number of extractions is 1-3 times; in step (2), the centrifugal speed is 3000-5000r / min, and the centrifugal time is 10-20min.

[0017] Specifically, in step (S2), the first chromatographic column is one of HPD1000 macroporous resin column, XAD-16 macroporous resin column, H103 macroporous resin column, AB-8 macroporous resin column or NKA-II macroporous resin column.

[0018] Specifically, in step (S4), the microsphere resin is one of KB-2 microsphere resin, NX-9 microsphere resin or NX-8 microsphere resin.

[0019] Specifically, in step (S5), the second chromatographic column is a Sephadex G10 chromatographic column or a C18 chromatographic column.

[0020] Specifically, before steps (S1), (S4), and (S5), a pretreatment step is also included, specifically, soaking the first chromatographic column, microsphere resin, and second chromatographic column used in the test in anhydrous ethanol for 12-18 hours, and then washing and soaking them with deionized water.

[0021] According to another aspect of the present application, cordycepin is obtained according to any of the cordycepin purification methods described above.

[0022] Specifically, the purity of the cordycepin is higher than 81%.

[0023] The present application also provides an application method of cordycepin, and its application in drugs for preventing and / or treating obesity, hyperlipidemia, and coronary heart disease.

[0024] The beneficial effects of the present invention include but are not limited to:

[0025] 1. According to a cordycepin purification method provided by the present invention, a systematic method for separating and purifying cordycepin from a crude extract is established, the process steps are optimized, the purity of cordycepin is improved, and a foundation is laid for expanding the research and application of cordycepin.

[0026] 2. According to a cordycepin purification method provided by the present invention, alcohol precipitation extraction technology is integrated to further optimize the initial purification process of cordycepin, remove water-soluble impurities such as protein and polysaccharide in the crude extract, and improve the purity of cordycepin in the crude extract.

[0027] 3. According to a cordycepin purification method provided by the present invention, a process for further purifying cordycepin by combining macroporous resin with microsphere resin is established, and the purity of cordycepin in the preliminary purified cordycepin product is increased by more than 3 times, with excellent purification effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:

[0029] Figure 1 The effect of alcohol precipitation on the purification of cordycepin in the examples of this application;

[0030] Figure 2 The effect of the ethanol concentration of the eluent on the purification results of cordycepin in the examples of this application;

[0031] Figure 3 The figure shows the influence of the concentration change of the ethanol solution flowing through the microsphere resin column on the purification result of cordycepin in the examples of the present application. DETAILED DESCRIPTION

[0032] The present invention is further described below in conjunction with specific embodiments. It is pointed out that the following embodiments cannot be understood as limiting the scope of protection of the present invention. A person of ordinary skill in the art can make some simple substitutions or adjustments based on the content of the present invention, which are all within the scope of protection of the present invention. Unless otherwise specified, the raw materials in the embodiments of the present application are purchased through commercial channels.

[0033] Example 1 Effect of alcohol precipitation on the purification of cordycepin

[0034] (1) Take 300 ml of the crude cordycepin extract, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60% and 80%, let it stand for 16 hours, centrifuge it at 5000 r / min for 15 minutes, collect the supernatant, and concentrate it using a rotary evaporator in a 60°C water bath to 250 ml to obtain an alcohol precipitate.

[0035] (2) The alcohol precipitate was passed through a macroporous resin NKA-II resin column at a rate of 3 BV / h; the macroporous resin was eluted under the condition that the eluent was 5 BV of a 70% ethanol solution to obtain a first eluate.

[0036] The cordycepin crude extract without anhydrous ethanol was used as the blank control group, and the cordycepin content of the first eluate was measured. The specific results are as follows: Figure 1 shown.

[0037] After the crude extract of cordycepin was precipitated by alcohol, it passed through the macroporous resin NKA-II resin column. The content of cordycepin in the eluent was higher than that in the control. The cordycepin content in the alcohol-precipitated sample with an ethanol concentration of 60% was the highest. The purity of the concentrated freeze-dried powder of cordycepin in the eluent reached 9.47%, which was more than 2 times higher than that in the control group (4.29%). Therefore, the optimal ethanol concentration for the alcohol precipitation of the crude extract of cordycepin was determined to be 60%.

[0038] Example 2 Effect of different first chromatographic columns on the initial purification of cordycepin

[0039] Under the optimized alcohol precipitation conditions obtained in Example 1, a single factor experiment for cordycepin purification was carried out with the first chromatographic column as a variable. The specific operation method is as follows:

[0040] (1) Take 300 mL of the crude cordycepin extract, add anhydrous ethanol until the ethanol concentration in the solution reaches 60%, let it stand for 16 hours, centrifuge it at 5000 r / min for 15 minutes, collect the supernatant, and concentrate it using a rotary evaporator in a 60° C. water bath to 250 mL to obtain an alcohol precipitate;

[0041] (2) Soak the HPD1000 macroporous resin, XAD-16 macroporous resin, H103 macroporous resin, AB-8 macroporous resin, and NKA-II macroporous resin in anhydrous ethanol for 12 h, discard the suspended matter, wash with deionized water until there is no alcohol smell, soak in deionized water, and set aside.

[0042] (3) taking a cordycepin standard solution, passing it through HPD1000 macroporous resin, XAD-16 macroporous resin, H103 macroporous resin, AB-8 macroporous resin, and NKA-II macroporous resin chromatography at a sample flow rate of 3 BV / h, respectively, and collecting the adsorption residual liquid; using an eluent of 5 BV of 70% ethanol solution as the elution condition, eluting the HPD1000 macroporous resin, XAD-16 macroporous resin, H103 macroporous resin, AB-8 macroporous resin, and NKA-II macroporous resin to obtain a first eluent;

[0043] (4) The adsorption residual liquid and the first eluent are filtered through microporous filter membranes respectively.

[0044] The cordycepin content in the supernatant was determined by high performance liquid chromatography, and the adsorption and desorption rates of cordycepin in the cordycepin standard solution by the above different macroporous resins were calculated.

[0045] Adsorption rate = (C-C1) / C×100%; desorption rate = C2 / (C-C1)×100%; where C is the initial concentration of cordycepin in the cordycepin standard solution (mg·mL-1), C1 is the cordycepin concentration in the adsorption residual solution (mg / mL), and C2 is the cordycepin concentration in the eluent (mg·mL -1 ), the specific results are shown in Table 1 below.

[0046] Among them, NKA-II resin had the highest cordycepin yield, so NKA-II was selected as the carrier for the preliminary purification of cordycepin.

[0047]

[0048] Table 1

[0049] Example 3 Effects of different sample loading flow rates on the purification results of cordycepin

[0050] Under the optimized alcohol precipitation conditions obtained in Example 1 and the optimized first chromatographic column conditions in Example 2, a single factor experiment for cordycepin purification was performed with the sample tassel as a variable. The specific operation method is as follows:

[0051] (1) Take 300 ml of the crude cordycepin extract, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000 r / min for 15 minutes, collect the supernatant, and concentrate it using a rotary evaporator in a 60°C water bath to 250 ml to obtain an alcohol precipitate.

[0052] (2) The alcohol precipitate was flowed through a macroporous resin NKA-II resin column at a rate of 0.5 BV / h, 1 BV / h, 2 BV / h, 3 BV / h, and 4 BV / h, respectively; the macroporous resin was eluted with an eluent of 5 BV of a 70% ethanol solution to obtain a first eluent.

[0053] The effect of sample flow rate on the dynamic adsorption rate of cordycepin by NKA-II resin column is shown in Table 2 below. The optimal sample flow rate is 3 BV / h.

[0054]

[0055] Table 2

[0056] Example 4 Effects of different sample loading amounts on cordycepin purification results

[0057] Under the optimized alcohol precipitation conditions obtained in Example 1, the optimized chromatographic column conditions obtained in Example 2, and the optimized loading flow rate obtained in Example 3, a cordycepin purification experiment was performed with different loading amounts as variables. The specific operation method is as follows:

[0058] (1) Take 300 ml of the crude cordycepin extract, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000 r / min for 15 minutes, collect the supernatant, and concentrate it using a rotary evaporator in a 60°C water bath to 250 ml to obtain an alcohol precipitate.

[0059] (2) 0.5 BV, 1 BV, 1.5 BV, 2 BV, and 2.5 BV of the alcohol precipitate were loaded and passed through a macroporous resin NKA-II resin column at a rate of 3 BV / h; the macroporous resin was eluted with 5 BV of an ethanol solution having a concentration of 70% as an eluent to obtain a first eluent.

[0060] The effect of sample loading volume on the dynamic adsorption rate of cordycepin by NKA-II resin column is shown in Table 3 below. The optimal sample loading volume is 1 BV.

[0061]

[0062] Table 3

[0063] Example 5Effect of ethanol concentration of eluent on purification of cordycepin

[0064] Under the optimized alcohol precipitation conditions obtained in Example 1 and the optimized chromatographic column conditions obtained in Example 2, a cordycepin purification experiment was carried out with different eluent concentrations as variables. The specific operation method is as follows:

[0065] (1) Take 300 ml of the crude cordycepin extract, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000 r / min for 15 minutes, collect the supernatant, and concentrate it using a rotary evaporator in a 60°C water bath to 250 ml to obtain an alcohol precipitate.

[0066] (2) taking the alcohol precipitate, passing it through a macroporous resin NKA-II resin column chromatography at a sample volume of 1 BV and a sample flow rate of 3 BV / h; using 5 BV of 10%, 20%, 30%, 40%, 50%, 60%, 70%, and 80% ethanol solutions as eluents to elute the macroporous resin, respectively, to obtain a first eluent.

[0067] Effects of different ethanol concentrations on the desorption rate of cordycepin from NKA-II resin. For specific results, see Figure 2 .

[0068] Example 6 Effects of different microsphere resins on the purification of cordycepin

[0069] Under the optimized alcohol precipitation conditions obtained in Example 1, the optimized chromatographic column conditions obtained in Example 2, the optimized loading flow rate obtained in Example 3, the optimized loading amount obtained in Example 4, and the optimized eluent ethanol concentration obtained in Example 5, the microsphere resin was used as a variable to perform a cordycepin purification experiment. The specific operation method is as follows:

[0070] (1) Take the crude cordycepin extract respectively, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000r / min for 15 minutes, collect the supernatant, and concentrate it with a rotary evaporator in a 60°C water bath to 250mL to obtain an alcohol precipitate.

[0071] (2) The alcohol precipitate was passed through a macroporous resin NKA-II resin column chromatography with a sample volume of 1 BV and a sample flow rate of 3 BV / h; the macroporous resin was eluted with an eluent of 5 BV of a 70% ethanol solution to obtain a first eluent.

[0072] (3) passing the first eluent through an alumina silica gel column at a rate of 3 BV / h, and collecting the remaining liquid;

[0073] (4) After the residual liquid is separated into KB-2 (polar) microsphere resin, NX-9 (polar) microsphere resin, and NX-8 (weakly polar) microsphere resin, the residual liquid is collected, and a 50% ethanol solution is added to the microsphere resin for desorption to obtain a second eluent;

[0074] The adsorption residual liquid and the second eluate were filtered through a 0.45 μm microporous filter membrane, respectively. The cordycepin content between the adsorption residual liquid and the second eluate was determined by high performance liquid chromatography, and the adsorption rate and desorption rate of cordycepin in the cordycepin standard solution by different microsphere resins were calculated according to the following formula.

[0075] Adsorption rate = (C-C1) / C×100%; desorption rate = C2 / (C-C1)×100%; where C is the initial concentration of cordycepin in the cordycepin standard solution (mg·mL-1), C1 is the cordycepin concentration in the adsorption residual solution (mg / mL), and C2 is the cordycepin concentration in the eluent (mg·mL -1 ). The specific results are shown in Table 4 below.

[0076]

[0077] Table 4

[0078] Example 7 Concentration changes of ethanol solution flowing through microsphere resin column

[0079] Under the optimized alcohol precipitation conditions obtained in Example 1, the optimized chromatographic column conditions obtained in Example 2, the optimized loading flow rate obtained in Example 3, the optimized loading amount obtained in Example 4, the optimized eluent ethanol concentration obtained in Example 5, and the optimized microsphere resin conditions obtained in Example 6, the cordycepin purification experiment was carried out with the ethanol concentration flowing through the microsphere resin column as a variable. The specific operation method is as follows:

[0080] (1) Take the crude cordycepin extract respectively, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000r / min for 15 minutes, collect the supernatant, and concentrate it with a rotary evaporator in a 60°C water bath to 250mL to obtain an alcohol precipitate.

[0081] (2) The alcohol precipitate was passed through a macroporous resin NKA-II resin column for chromatography; the macroporous resin was eluted under the conditions of 5 BV of 70% ethanol solution and a sample loading flow rate of 3 BV / h to obtain a first eluate.

[0082] (3) passing the first eluent through an alumina silica gel column at a rate of 3 BV / h, and collecting the remaining liquid;

[0083] (4) After the residual liquid is separated from the KB-2 (polar) microsphere resin, the residual liquid is collected and desorbed into the microsphere resin using 10%, 20%, 30%, 40%, 50%, 60%, and 70% ethanol solutions, respectively, to obtain a second eluent;

[0084] Detect the cordycepin concentration in the second eluate. See the specific results in Figure 3 When the ethanol concentration was 20%, the cordycepin resolution rate of KB-2 microsphere resin reached the maximum value.

[0085] Example 8 Effects of different second chromatographic columns on the purification of cordycepin

[0086] Under the optimized alcohol precipitation conditions obtained in Example 1, the optimized chromatographic column conditions obtained in Example 2, the optimized loading flow rate obtained in Example 3, the optimized loading amount obtained in Example 4, the optimized elution ethanol concentration obtained in Example 5, the microsphere resin conditions obtained in Example 6, and the ethanol flow rate flowing through the microsphere resin obtained in Example 7, a cordycepin purification experiment was performed. The specific operation method is as follows:

[0087] (1) Take the crude cordycepin extract respectively, slowly add anhydrous ethanol while stirring to make the ethanol concentration in the solution reach 60%, let it stand for 16 hours, centrifuge it at 5000r / min for 15 minutes, collect the supernatant, and concentrate it with a rotary evaporator in a 60°C water bath to 250mL to obtain an alcohol precipitate.

[0088] (2) The alcohol precipitate was passed through a macroporous resin NKA-II resin column for chromatography; the macroporous resin was eluted under the conditions of 5 BV of 70% ethanol solution and a sample loading flow rate of 3 BV / h to obtain a first eluate.

[0089] (3) passing the first eluent through an alumina silica gel column at a rate of 3 BV / h, and collecting the remaining liquid;

[0090] (4) After the residual liquid passes through the KB-2 (polar) microsphere resin, the residual liquid is collected and desorbed into the microsphere resin using 2.8 BV of a 20% ethanol solution to obtain a second eluent;

[0091] (5) passing the second eluent through a Sepdex G10 column and a C18 column, eluting the Sepdex G10 column with deionized water, and eluting the C18 column with a gradient of 5%-100% ethanol solution, collecting the eluents with a cordycepin peak area of ​​more than 90%, and drying them to obtain a purified product; repeatedly washing and crystallizing the purified product with anhydrous ethanol to obtain purified cordycepin.

[0092] The effects of different carriers on the purification of cordycepin can be seen in Table 5 below.

[0093] Sephdex G10 column and C18 column have similar effects on cordycepin purification, and both can increase the purity of cordycepin in the sample by nearly 2 times. However, in comparison, the sample carrying capacity of Sephdex G10 column is greater than that of C18 column, the elution procedure is simple, and the cost of elution solution is low, which is suitable for mass production of cordycepin purification. Therefore, Sephdex G10 column was selected as the cordycepin purification carrier.

[0094]

[0095] Table 5

[0096] The above is only the embodiment of the present application, and the protection scope of the present application is not limited by these specific embodiments, but is determined by the claims of the present application. For those skilled in the art, the present application can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the technical ideas and principles of the present application should be included in the protection scope of the present application.

Claims

1. A method for purifying cordycepin, characterized in that: The following steps are involved: (S1) taking a crude cordycepin extract, adding anhydrous ethanol until the ethanol concentration in the solution reaches 60%-80%, standing for 12-18 hours, centrifuging and collecting the supernatant to obtain a first supernatant, and concentrating the first supernatant to 3-3.5 times the mass of the first supernatant in a water bath at 50° C.-70° C. to obtain an alcohol precipitate; (S2) passing the alcohol precipitate through a first chromatography column for chromatography, with a sample loading volume of 0.5-2.5 BV and a sample loading flow rate of 1-3 BV / h; eluting the first chromatography column to obtain a first eluent, wherein the eluent is 3-5 BV of a 50%-70% ethanol solution; (S3) passing the first eluent through an alumina silica gel column at a rate of 2-4 BV / h, and collecting the remaining liquid; (S4) after the residual liquid flows through the microsphere resin column, 2-3 BV of 10%-70% ethanol solution is added for desorption to obtain a second eluent; (S5) passing the second eluent through a second chromatographic column to elute the second chromatographic column, collecting the eluent with a cordycepin peak area of ​​more than 90%, and drying to obtain a purified product; repeatedly washing and crystallizing the purified product with anhydrous ethanol to obtain purified cordycepin.

2. The method for purifying cordycepin according to claim 1, characterized in that: Before step (S1), the method further includes extracting a crude cordycepin extract, which includes the following steps: (1) drying the fruiting bodies cultivated by the Cordyceps militaris strain at 50-60° C. to constant weight, and crushing the fruiting bodies through a 75-85 mesh sieve to obtain dry matter of the fruiting bodies cultivated by the Cordyceps militaris strain; (2) extracting the dry matter of the fruiting bodies cultivated by the Cordyceps militaris strain by water bath reflux, collecting the second supernatant by centrifugation, and concentrating the second supernatant to 3-3.5 times of the second supernatant by mass in a water bath at 50-70° C. to obtain a crude extract.

3. The method for purifying cordycepin according to claim 2, characterized in that: In step (1), the water bath reflux extraction temperature is 50-90°C, the extraction time is 1-5h, the purification concentration is 10-60%, the solid-liquid ratio is 1:(10-80), and the number of extractions is 1-3 times; in step (2), the centrifugal speed is 3000-5000r / min, and the centrifugal time is 10-20min.

4. The method for purifying cordycepin according to claim 1, characterized in that: In step (S2), the first chromatographic column is one of HPD1000 macroporous resin column, XAD-16 macroporous resin column, H103 macroporous resin column, AB-8 macroporous resin column or NKA-II macroporous resin column.

5. The method for purifying cordycepin according to claim 1, characterized in that: In step (S4), the microsphere resin is one of KB-2 microsphere resin, NX-9 microsphere resin or NX-8 microsphere resin.

6. The method for purifying cordycepin according to claim 1, characterized in that: In step (S5), the second chromatographic column is a Sephadex G10 chromatographic column or a C18 chromatographic column.

7. The method for purifying cordycepin according to claim 1, characterized in that: Before steps (S1), (S4) and (S5), a pretreatment step is also included, specifically, the first chromatographic column, microsphere resin and second chromatographic column used in the test are soaked in anhydrous ethanol for 12-18 hours, and then washed and soaked with deionized water.

8. Cordycepin obtained by the cordycepin purification method according to any one of claims 1 to 7.

9. The cordycepin according to claim 8, characterized in that The purity of the cordycepin is higher than 81%.

10. A method for using cordycepin according to claim 9, characterized in that: The application of cordycepin in drugs for preventing and / or treating obesity, hyperlipidemia and coronary heart disease.